{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T21:29:53Z","timestamp":1786483793797,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CLAIMS project, funded by the Innovative Health Initiative Joint Undertaking","award":["101112153"],"award-info":[{"award-number":["101112153"]}]},{"name":"CLAIMS project, funded by the Innovative Health Initiative Joint Undertaking","award":["101112153"],"award-info":[{"award-number":["101112153"]}]},{"name":"CLAIMS project, funded by the Innovative Health Initiative Joint Undertaking","award":["101112153"],"award-info":[{"award-number":["101112153"]}]},{"name":"CLAIMS project, funded by the Innovative Health Initiative Joint Undertaking","award":["101112153"],"award-info":[{"award-number":["101112153"]}]},{"name":"CLAIMS project, funded by the Innovative Health Initiative Joint Undertaking","award":["101112153"],"award-info":[{"award-number":["101112153"]}]},{"name":"research agreement between Bristol-Myers Squibb and icometrix"},{"name":"ITEA grant from Flanders Innovation and Entrepreneurship.","award":["20030 HeKDisco, HBC.2021.0500"],"award-info":[{"award-number":["20030 HeKDisco, HBC.2021.0500"]}]},{"name":"ITEA grant from Flanders Innovation and Entrepreneurship.","award":["20030 HeKDisco, HBC.2021.0500"],"award-info":[{"award-number":["20030 HeKDisco, HBC.2021.0500"]}]},{"name":"ITEA grant from Flanders Innovation and Entrepreneurship.","award":["20030 HeKDisco, HBC.2021.0500"],"award-info":[{"award-number":["20030 HeKDisco, HBC.2021.0500"]}]},{"name":"ITEA grant from Flanders Innovation and Entrepreneurship.","award":["20030 HeKDisco, HBC.2021.0500"],"award-info":[{"award-number":["20030 HeKDisco, HBC.2021.0500"]}]},{"name":"ITEA grant from Flanders Innovation and Entrepreneurship.","award":["20030 HeKDisco, HBC.2021.0500"],"award-info":[{"award-number":["20030 HeKDisco, HBC.2021.0500"]}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1SD5322N, 12A6U25N, 1805620N"],"award-info":[{"award-number":["1SD5322N, 12A6U25N, 1805620N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1SD5322N, 12A6U25N, 1805620N"],"award-info":[{"award-number":["1SD5322N, 12A6U25N, 1805620N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Subjective cognitive performance in multiple sclerosis (MS) correlates weakly with objective performance, but is more strongly associated with depression. We aimed to identify symptoms and brain MRI volumes related to subjective and objective cognitive performance. 205 MS subjects, diagnosed within the last 15 years, completed the SymptoMScreen, patient-reported Expanded Disability Status Scale, Neuro-QoL subjective cognitive and fatigue sub-scores, and Beck Depression Inventory. For the objective cognitive assessment the smartphone-based icompanion Symbol test was used. Volumetric variables were calculated from the 52 available brain MRIs using icobrain. A weak correlation was observed between subjective and objective performance (rho\u2009=\u20090.21,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.002). Subjective performance was negatively associated with pain, dizziness, fatigue and depression, while objective performance was negatively related to walking impairment. Objective performance significantly correlated with thalamic volume, while subjective performance did not correlate with any brain volumes. In other words, subjective and objective cognitive performance are related to different clinical markers: subjective performance is linked to invisible symptoms, while objective performance is linked to more visible measurable clinical markers. Integrating both perspectives in clinical practice may provide a more holistic understanding of cognition in MS, allowing for tailored interventions that enhance patient care and quality of life.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-48645-6","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:57:20Z","timestamp":1778911040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The relationship between objective and subjective cognitive performance and clinical and MRI disease burden in early multiple sclerosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Delphine","family":"Van Laethem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Costers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Miravalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bennett","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Boster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Al Halawani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Dewil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Cambron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Grothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"Denissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Bartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Sima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemie","family":"Ribbens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Nagels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"issue":"14","key":"48645_CR1","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton, C. et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 26 (14), 1816\u20131821 (2020).","journal-title":"Mult Scler."},{"issue":"10","key":"48645_CR2","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","volume":"19","author":"RHB Benedict","year":"2020","unstructured":"Benedict, R. H. B., Amato, M. P., DeLuca, J. & Geurts, J. J. G. Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol. 19 (10), 860\u2013871 (2020).","journal-title":"Lancet Neurol."},{"issue":"13","key":"48645_CR3","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1177\/1352458519881760","volume":"26","author":"R Brandstadter","year":"2020","unstructured":"Brandstadter, R. et al. Word-finding difficulty is a prevalent disease-related deficit in early multiple sclerosis. Mult Scler. Houndmills Basingstoke Engl. 26 (13), 1752\u20131764 (2020).","journal-title":"Mult Scler. Houndmills Basingstoke Engl."},{"key":"48645_CR4","doi-asserted-by":"publisher","first-page":"104579","DOI":"10.1016\/j.msard.2023.104579","volume":"71","author":"T Grezmak","year":"2023","unstructured":"Grezmak, T., Lace, J. W., Nakamura, K., Ontaneda, D. & Galioto, R. It\u2019s on the tip of my tongue! exploring confrontation naming difficulties in patients with multiple sclerosis. Mult Scler. Relat. Disord. 71, 104579 (2023).","journal-title":"Mult Scler. Relat. Disord"},{"issue":"6","key":"48645_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000004977","volume":"90","author":"JF Sumowski","year":"2018","unstructured":"Sumowski, J. F. et al. Cognition in multiple sclerosis: State of the field and priorities for the future. Neurology 90 (6), 278\u2013288 (2018).","journal-title":"Neurology"},{"issue":"5","key":"48645_CR6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/1352458517690821","volume":"23","author":"RHB Benedict","year":"2017","unstructured":"Benedict, R. H. B. et al. Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis. Mult Scler. 23 (5), 721\u2013733 (2017).","journal-title":"Mult Scler."},{"key":"48645_CR7","doi-asserted-by":"publisher","first-page":"e53503","DOI":"10.2196\/53503","volume":"27","author":"S Denissen","year":"2025","unstructured":"Denissen, S. et al. A New Smartphone-Based Cognitive Screening Battery for Multiple Sclerosis (icognition): Validation Study. J. Med. Internet Res. 27, e53503 (2025).","journal-title":"J. Med. Internet Res."},{"issue":"1","key":"48645_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1191\/1352458503ms861oa","volume":"9","author":"RHB Benedict","year":"2003","unstructured":"Benedict, R. H. B. et al. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler. 9 (1), 95\u2013101 (2003).","journal-title":"Mult Scler."},{"issue":"2","key":"48645_CR9","first-page":"99","volume":"4","author":"MJ Sullivan","year":"1990","unstructured":"Sullivan, M. J., Edgley, K. & Dehoux, E. A survey of multiple sclerosis: I. Perceived cognitive problems and compensatory strategy use. Can. J. Rehabil. 4 (2), 99\u2013105 (1990).","journal-title":"Can. J. Rehabil"},{"issue":"3","key":"48645_CR10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/13524585241309805","volume":"31","author":"JF Sumowski","year":"2025","unstructured":"Sumowski, J. F. & Sandry, J. Multiple Sclerosis Cognitive Scale (MSCS): A brief psychometrically robust metric of patient-reported cognitive difficulty. Mult Scler. Houndmills Basingstoke Engl. 31 (3), 352\u2013362 (2025).","journal-title":"Mult Scler. Houndmills Basingstoke Engl."},{"issue":"1","key":"48645_CR11","first-page":"205521731982761","volume":"5","author":"I Kletenik","year":"2019","unstructured":"Kletenik, I. et al. Subjective cognitive concern in multiple sclerosis is associated with reduced thalamic and cortical gray matter volumes. Mult Scler. J. - Exp. Transl Clin. 5 (1), 205521731982761 (2019).","journal-title":"Mult Scler. J. - Exp. Transl Clin."},{"issue":"1","key":"48645_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/ene.13784","volume":"26","author":"PL Jelinek","year":"2019","unstructured":"Jelinek, P. L. et al. Self-reported cognitive function in a large international cohort of people with multiple sclerosis: associations with lifestyle and other factors. Eur. J. Neurol. 26 (1), 142\u2013154 (2019).","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"48645_CR13","first-page":"131","volume":"7","author":"Y Maor","year":"2001","unstructured":"Maor, Y., Olmer, L. & Mozes, B. The relation between objective and subjective impairment in cognitive function among multiple sclerosis patients\u2013the role of depression. Mult Scler. 7 (2), 131\u2013135 (2001).","journal-title":"Mult Scler."},{"issue":"1","key":"48645_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/1352458506070255","volume":"13","author":"L Julian","year":"2007","unstructured":"Julian, L., Merluzzi, N. M. & Mohr, D. C. The relationship among depression, subjective cognitive impairment, and neuropsychological performance in multiple sclerosis. Mult Scler. 13 (1), 81\u201386 (2007).","journal-title":"Mult Scler."},{"issue":"5","key":"48645_CR15","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1177\/1352458518769837","volume":"25","author":"G Kobelt","year":"2019","unstructured":"Kobelt, G., Langdon, D. & J\u00f6nsson, L. The effect of self-assessed fatigue and subjective cognitive impairment on work capacity: The case of multiple sclerosis. Mult Scler. J. 25 (5), 740\u2013749 (2019).","journal-title":"Mult Scler. J."},{"key":"48645_CR16","doi-asserted-by":"publisher","first-page":"104410","DOI":"10.1016\/j.msard.2022.104410","volume":"69","author":"DA Jackson","year":"2023","unstructured":"Jackson, D. A. et al. Cognitive impairment in people with multiple sclerosis: Perception vs. performance - factors that drive perception of impairment differ for patients and clinicians. Mult Scler. Relat. Disord. 69, 104410 (2023).","journal-title":"Mult Scler. Relat. Disord"},{"key":"48645_CR17","doi-asserted-by":"crossref","unstructured":"Benedict, R. H. B. & Zivadinov, R. Predicting neuropsychological abnormalities in multiple sclerosis. J. Neurol. Sci. 2006 June 15;245(1\u20132):67\u201372 .","DOI":"10.1016\/j.jns.2005.05.020"},{"issue":"6","key":"48645_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1191\/1352458504ms1098oa","volume":"10","author":"RHB Benedict","year":"2004","unstructured":"Benedict, R. H. B. et al. Reliable screening for neuropsychological impairment in multiple sclerosis. Mult Scler. 10 (6), 675\u2013678 (2004).","journal-title":"Mult Scler."},{"key":"48645_CR19","doi-asserted-by":"publisher","first-page":"101904","DOI":"10.1016\/j.msard.2019.101904","volume":"39","author":"MB D\u2019Hooghe","year":"2020","unstructured":"D\u2019Hooghe, M. B. et al. Correlations of health status indicators with perceived neuropsychological impairment and cognitive processing speed in multiple sclerosis. Mult Scler. Relat. Disord. 39, 101904 (2020).","journal-title":"Mult Scler. Relat. Disord"},{"issue":"8","key":"48645_CR20","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.acn.2007.07.002","volume":"22","author":"A O\u2019Brien","year":"2007","unstructured":"O\u2019Brien, A. et al. Relationship of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) to functional, emotional, and neuropsychological outcomes. Arch. Clin. Neuropsychol. 22 (8), 933\u2013948 (2007).","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"1","key":"48645_CR21","first-page":"1","volume":"12","author":"D Van Laethem","year":"2022","unstructured":"Van Laethem, D. et al. Correlates of patient-reported cognitive performance with regard to disability. Sci. Rep. 2022 121. 12 (1), 1\u20138 (2022).","journal-title":"Sci. Rep. 2022 121"},{"issue":"5","key":"48645_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/ane.12238","volume":"130","author":"E Rosti-Otaj\u00e4rvi","year":"2014","unstructured":"Rosti-Otaj\u00e4rvi, E., Ruutiainen, J., Huhtala, H. & H\u00e4m\u00e4l\u00e4inen, P. Relationship between subjective and objective cognitive performance in multiple sclerosis. Acta Neurol. Scand. 130 (5), 319\u2013327 (2014).","journal-title":"Acta Neurol. Scand."},{"key":"48645_CR23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.msard.2019.01.055","volume":"30","author":"AJ Hughes","year":"2019","unstructured":"Hughes, A. J., Bhattarai, J. J., Paul, S. & Beier, M. Depressive symptoms and fatigue as predictors of objective-subjective discrepancies in cognitive function in multiple sclerosis. Mult Scler. Relat. Disord. 30, 192\u2013197 (2019).","journal-title":"Mult Scler. Relat. Disord"},{"issue":"2","key":"48645_CR24","first-page":"169","volume":"38","author":"GA Thomas","year":"2023","unstructured":"Thomas, G. A., Riegler, K. E., Bradson, M. L., O\u2019Shea, D. U. & Arnett, P. A. Subjective Report, Objective Neurocognitive Performance, and Invisible Symptoms in Multiple Sclerosis. Arch. Clin. Neuropsychol. Off J. Natl. Acad. Neuropsychol. 38 (2), 169\u2013181 (2023).","journal-title":"Arch. Clin. Neuropsychol. Off J. Natl. Acad. Neuropsychol."},{"issue":"1","key":"48645_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1191\/1352458505ms1110oa","volume":"11","author":"RA Marrie","year":"2005","unstructured":"Marrie, R. A., Chelune, G. J., Miller, D. M. & Cohen, J. A. Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosis. Mult Scler. 11 (1), 69\u201375 (2005).","journal-title":"Mult Scler."},{"issue":"4","key":"48645_CR26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1177\/1352458520922830","volume":"27","author":"L Glukhovsky","year":"2021","unstructured":"Glukhovsky, L. et al. Hippocampal volume is more related to patient-reported memory than objective memory performance in early multiple sclerosis. Mult Scler. J. 27 (4), 568\u2013578 (2021).","journal-title":"Mult Scler. J."},{"issue":"12","key":"48645_CR27","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/ene.14012","volume":"26","author":"MB D\u2019hooghe","year":"2019","unstructured":"D\u2019hooghe, M. B. et al. Perceived neuropsychological impairment inversely related to self-reported health and employment in multiple sclerosis. Eur. J. Neurol. 26 (12), 1447\u20131454 (2019).","journal-title":"Eur. J. Neurol."},{"key":"48645_CR28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ibneur.2022.10.016","volume":"13","author":"J van Wegen","year":"2022","unstructured":"van Wegen, J. et al. Subjective cognitive impairment is related to work status in people with multiple sclerosis. IBRO Neurosci. Rep. 13, 513\u2013522 (2022).","journal-title":"IBRO Neurosci. Rep."},{"issue":"2","key":"48645_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17 (2), 162\u2013173 (2018).","journal-title":"Lancet Neurol."},{"key":"48645_CR30","doi-asserted-by":"crossref","unstructured":"Van Hecke, W. et al. A Novel Digital Care Management Platform to Monitor Clinical and Subclinical Disease Activity in Multiple Sclerosis. Brain Sci. Sept 1;11(9):1171. (2021).","DOI":"10.3390\/brainsci11091171"},{"issue":"2","key":"48645_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/23279095.2015.1125905","volume":"24","author":"R Green","year":"2017","unstructured":"Green, R., Kalina, J., Ford, R., Pandey, K. & Kister, I. SymptoMScreen: A Tool for Rapid Assessment of Symptom Severity in MS Across Multiple Domains. Appl. Neuropsychol. Adult. 24 (2), 183\u2013189 (2017).","journal-title":"Appl. Neuropsychol. Adult"},{"key":"48645_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.msard.2019.01.031","volume":"29","author":"KC Fitzgerald","year":"2019","unstructured":"Fitzgerald, K. C. et al. Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes. Mult Scler. Relat. Disord. 29, 86\u201393 (2019).","journal-title":"Mult Scler. Relat. Disord"},{"issue":"10","key":"48645_CR33","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1007\/s00415-013-7004-1","volume":"260","author":"S Leddy","year":"2013","unstructured":"Leddy, S., Hadavi, S., McCarren, A., Giovannoni, G. & Dobson, R. Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis. J. Neurol. 260 (10), 2505\u20132510 (2013).","journal-title":"J. Neurol."},{"issue":"4","key":"48645_CR34","first-page":"205521731988598","volume":"5","author":"LD Medina","year":"2019","unstructured":"Medina, L. D., Torres, S., Alvarez, E., Valdez, B. & Nair, K. V. Patient-reported outcomes in multiple sclerosis: Validation of the Quality of Life in Neurological Disorders (Neuro-QoL\u2122) short forms. Mult Scler. J. - Exp. Transl Clin. 5 (4), 2055217319885986 (2019).","journal-title":"Mult Scler. J. - Exp. Transl Clin."},{"issue":"1","key":"48645_CR35","first-page":"126","volume":"36","author":"GL Iverson","year":"2021","unstructured":"Iverson, G. L., Connors, E. J., Marsh, J. & Terry, D. P. Examining Normative Reference Values and Item-Level Symptom Endorsement for the Quality of Life in Neurological Disorders (Neuro-QoL\u2122) v2.0 Cognitive Function-Short Form. Arch. Clin. Neuropsychol. Off J. Natl. Acad. Neuropsychol. 36 (1), 126\u2013134 (2021).","journal-title":"Arch. Clin. Neuropsychol. Off J. Natl. Acad. Neuropsychol."},{"issue":"4","key":"48645_CR36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1191\/1352458503ms902oa","volume":"9","author":"RHB Benedict","year":"2003","unstructured":"Benedict, R. H. B., Fishman, I., McClellan, M. M., Bakshi, R. & Weinstock-Guttman, B. Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis. Mult Scler. 9 (4), 393\u2013396 (2003).","journal-title":"Mult Scler."},{"issue":"11","key":"48645_CR37","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke, J. F. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33 (11), 1444\u20131452 (1983).","journal-title":"Neurology"},{"key":"48645_CR38","doi-asserted-by":"publisher","first-page":"102707","DOI":"10.1016\/j.nicl.2021.102707","volume":"31","author":"M Raki\u0107","year":"2021","unstructured":"Raki\u0107, M. et al. icobrain ms 5.1: Combining unsupervised and supervised approaches for improving the detection of multiple sclerosis lesions. NeuroImage Clin. 31, 102707 (2021).","journal-title":"NeuroImage Clin."},{"issue":"1","key":"48645_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00234-022-03074-w","volume":"65","author":"Z Mendelsohn","year":"2023","unstructured":"Mendelsohn, Z. et al. Commercial volumetric MRI reporting tools in multiple sclerosis: a systematic review of the evidence. Neuroradiology 65 (1), 5\u201324 (2023).","journal-title":"Neuroradiology"},{"issue":"1","key":"48645_CR40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R Stat. Soc. Ser. B Methodol. 57 (1), 289\u2013300 (1995).","journal-title":"J. R Stat. Soc. Ser. B Methodol."},{"issue":"4","key":"48645_CR41","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13760-013-0198-2","volume":"113","author":"M Ghajarzadeh","year":"2013","unstructured":"Ghajarzadeh, M. et al. Fatigue in multiple sclerosis: relationship with disease duration, physical disability, disease pattern, age and sex. Acta Neurol. Belg. 113 (4), 411\u2013414 (2013).","journal-title":"Acta Neurol. Belg."},{"key":"48645_CR42","doi-asserted-by":"publisher","first-page":"103954","DOI":"10.1016\/j.msard.2022.103954","volume":"64","author":"H Moore","year":"2022","unstructured":"Moore, H. et al. Fatigue in multiple sclerosis: A UK MS-register based study. Mult Scler. Relat. Disord. 64, 103954 (2022).","journal-title":"Mult Scler. Relat. Disord"},{"key":"48645_CR43","doi-asserted-by":"crossref","unstructured":"Benedict, R. H. B. et al. Upper and lower extremity motor function and cognitive impairment in multiple sclerosis. J. Int. Neuropsychol. Soc. 17 (4), 643\u2013653 (2011 July).","DOI":"10.1017\/S1355617711000403"},{"issue":"1\u20132","key":"48645_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jns.2012.02.003","volume":"316","author":"VL D\u2019Orio","year":"2012","unstructured":"D\u2019Orio, V. L. et al. Cognitive and motor functioning in patients with multiple sclerosis: Neuropsychological predictors of walking speed and falls. J. Neurol. Sci. 316 (1\u20132), 42\u201346 (2012).","journal-title":"J. Neurol. Sci."},{"issue":"1\u20132","key":"48645_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jns.2013.09.024","volume":"335","author":"RW Motl","year":"2013","unstructured":"Motl, R. W. et al. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores. J. Neurol. Sci. 335 (1\u20132), 169\u2013173 (2013).","journal-title":"J. Neurol. Sci."},{"key":"48645_CR46","doi-asserted-by":"crossref","unstructured":"van Schependom, J. & Nagels, G. Targeting cognitive impairment in multiple sclerosis-the road toward an imaging-based biomarker. Front. Neurosci. 30, 11:380 (2017 June).","DOI":"10.3389\/fnins.2017.00380"},{"issue":"2","key":"48645_CR47","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1001\/archneur.61.2.226","volume":"61","author":"RHB Benedict","year":"2004","unstructured":"Benedict, R. H. B. et al. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch. Neurol. 61 (2), 226\u2013230 (2004).","journal-title":"Arch. Neurol."},{"issue":"20","key":"48645_CR48","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1212\/01.wnl.0000435551.90824.d0","volume":"81","author":"M Filippi","year":"2013","unstructured":"Filippi, M. et al. Gray matter damage predicts the accumulation of disability 13 years later in MS. Neurology 81 (20), 1759\u20131767 (2013).","journal-title":"Neurology"},{"issue":"10","key":"48645_CR49","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/hbm.21125","volume":"32","author":"G Riccitelli","year":"2011","unstructured":"Riccitelli, G. et al. Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype. Hum. Brain Mapp. 32 (10), 1535\u20131543 (2011).","journal-title":"Hum. Brain Mapp."},{"issue":"1","key":"48645_CR50","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3174\/ajnr.A4952","volume":"38","author":"D Damjanovic","year":"2017","unstructured":"Damjanovic, D. et al. Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study. AJNR Am. J. Neuroradiol. 38 (1), 18 (2017).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"48645_CR51","doi-asserted-by":"crossref","unstructured":"Bergsland, N., Zivadinov, R., Dwyer, M. G., Weinstock-Guttman, B. & Benedict, R. H. Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients. Mult Scler. 22 (10), 1327\u20131336 (2016 Sept).","DOI":"10.1177\/1352458515616204"},{"issue":"17","key":"48645_CR52","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1212\/WNL.0b013e3182703f46","volume":"79","author":"MM Schoonheim","year":"2012","unstructured":"Schoonheim, M. M. et al. Subcortical atrophy and cognition: sex effects in multiple sclerosis. Neurology 79 (17), 1754\u20131761 (2012).","journal-title":"Neurology"},{"key":"48645_CR53","doi-asserted-by":"crossref","unstructured":"Van Der Werf, Y. D. et al. Thalamic volume predicts performance on tests of cognitive speed and decreases in healthy aging. A magnetic resonance imaging-based volumetric analysis. Brain Res. Cogn. Brain Res. 11 (3), 377\u2013385 (2001 June).","DOI":"10.1016\/S0926-6410(01)00010-6"},{"issue":"1","key":"48645_CR54","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40120-021-00239-2","volume":"10","author":"L Lakin","year":"2021","unstructured":"Lakin, L., Davis, B. E., Binns, C. C., Currie, K. M. & Rensel, M. R. Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms\u2014A Narrative Review. Neurol. Ther. 10 (1), 75\u201398 (2021).","journal-title":"Neurol. Ther."},{"issue":"23","key":"48645_CR55","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1080\/09638288.2020.1741698","volume":"43","author":"LS Parker","year":"2021","unstructured":"Parker, L. S., Topcu, G., De Boos, D. & das Nair, R. The notion of invisibility in people\u2019s experiences of the symptoms of multiple sclerosis: a systematic meta-synthesis. Disabil. Rehabil. 43 (23), 3276\u20133290 (2021).","journal-title":"Disabil. Rehabil"},{"issue":"2","key":"48645_CR56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/01376517-200804000-00007","volume":"40","author":"CP White","year":"2008","unstructured":"White, C. P., White, M. B. & Russell, C. S. Invisible and visible symptoms of multiple sclerosis: which are more predictive of health distress? J. Neurosci. Nurs. J. Am. Assoc. Neurosci. Nurses. 40 (2), 85\u201395 (2008).","journal-title":"J. Neurosci. Nurs. J. Am. Assoc. Neurosci. Nurses"},{"issue":"2","key":"48645_CR57","first-page":"263","volume":"60","author":"L Lorefice","year":"2018","unstructured":"Lorefice, L. et al. The impact of visible and invisible symptoms on employment status, work and social functioning in Multiple Sclerosis. Work Read. Mass. 60 (2), 263\u2013270 (2018).","journal-title":"Work Read. Mass."},{"issue":"3","key":"48645_CR58","first-page":"205521731772830","volume":"3","author":"R Green","year":"2017","unstructured":"Green, R., Cutter, G., Friendly, M. & Kister, I. Which symptoms contribute the most to patients\u2019 perception of health in multiple sclerosis? Mult Scler. J. - Exp. Transl Clin. 3 (3), 2055217317728301 (2017).","journal-title":"Mult Scler. J. - Exp. Transl Clin."},{"issue":"1","key":"48645_CR59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0022-510X(02)00312-X","volume":"205","author":"V Janardhan","year":"2002","unstructured":"Janardhan, V. & Bakshi, R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J. Neurol. Sci. 205 (1), 51\u201358 (2002).","journal-title":"J. Neurol. Sci."},{"key":"48645_CR60","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.msard.2019.01.049","volume":"30","author":"Y Yalachkov","year":"2019","unstructured":"Yalachkov, Y. et al. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis. Mult Scler. Relat. Disord. 30, 33\u201337 (2019).","journal-title":"Mult Scler. Relat. Disord"},{"issue":"13","key":"48645_CR61","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1177\/13524585251363747","volume":"31","author":"J Van Schependom","year":"2025","unstructured":"Van Schependom, J. & Cutter, G. Lost in dichotomization: Preserving statistical power and sensitivity in MS cognitive research. Mult Scler. Houndmills Basingstoke Engl. 31 (13), 1513\u20131517 (2025).","journal-title":"Mult Scler. Houndmills Basingstoke Engl."},{"issue":"4","key":"48645_CR62","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s00415-023-12102-5","volume":"271","author":"D Mistri","year":"2024","unstructured":"Mistri, D. et al. Cognitive phenotypes in multiple sclerosis: mapping the spectrum of impairment. J. Neurol. 271 (4), 1571\u20131583 (2024).","journal-title":"J. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48645-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:01:26Z","timestamp":1784080886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48645-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48645"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48645-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Lars Costers, Rebecca Bartz, Diana Sima, Annemie Ribbens and Dirk Smeets are employees of icometrix.\u00a0Enrique Alvarez has received compensation for activities such as advisory boards, lectures and consultancy with the following companies and organizations: Biogen, Celgene\/BMS, EMD Serono\/Merck, Genentech\/Roche, Horizon\/Amgen, Novartis, Sanofi, Cionic, and TG Therapeutics and research support from: Atara, Biogen, BMS, Genentech\/Roche, Novartis, Sanofi, TG Therapeutics, Patient-Centered Outcomes Research Initiative, National Multiple Sclerosis Society, National Institutes of Health, and Rocky Mountain MS Center.\u00a0Other authors have declared no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22224"}}